HOME >> BIOLOGY >> NEWS
Dentists abuzz over cavity-prevention potential of honeybee product

Dentists from the University of Rochester Medical Center and food scientists at State University of Campinas in Brazil have discovered that a substance that Brazilian honeybees make to protect their hives might prove to be a potent anti-cavity agent.

The substance is propolis, a sticky material like glue that bees make to hold their hives together. Bees create the brew by collecting secretions from trees and other plants, carrying them back to the hive, chewing up the materials, then spitting the concoction out and mixing it with beeswax. In a hive, the substance is used to seal holes, keep the hive clean, and even to embalm dead insects.

In laboratory tests, the most potent version of the substance, from southern Brazil, cut the cavity rate in rats by about 60 percent, and nearly stopped the activity of a key enzyme that forms dental plaque. Dentists say that since rats get cavities the same way as humans do, and the same substances that prevent cavities in the animals also prevent cavities in humans, theyre enthusiastic about the potential of the substance to prevent cavities in people. Dentists hope to test the substance on human volunteers. The link between hive and health was first noted by Michel Hyun Koo, D.D.S., Ph.D., who earned his dental degree in Brazil and then decided to study food biochemistry. Thanks in part to active honeybee research across campus at State University of Campinas, Koo began studying propolis and soon was traveling around Brazil collecting the material from hives, using a device like a putty knife to scrape the dark yellow or brown, caulk-like substance from hives. His first experience left him barely able to walk, as he received about two dozen stings around his ankles from angry bees because his black socks triggered the bees defensive behavior.

Brushing the pain aside, Koo persisted, focusing on the cavity-fighting potential of propolis as he earned his masters degree in food science and his doctor
'"/>

Contact: Tom Rickey
trickey@admin.rochester.edu
716-275-7954
University of Rochester Medical Center
29-Aug-2001


Page: 1 2 3 4

Related biology news :

1. Honey shines in athletic research, has scientific community abuzz
2. Award winning researchers reveal potential new role for Glivec
3. Evidence builds for potential new cancer drug target
4. Scientists discover potential new way to control drug-resistant bacteria
5. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
6. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
7. Managing occupational exposures to potential bioterrorist agents
8. Location of potential familial lung cancer gene discovered
9. Acamprosate: potential medication for treating alcoholism
10. Common chemicals morphing into potential toxins in Arctic
11. Yale researchers discover new potential asthma therapeutic targets related to parasites and insects

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
Cached News: